News | Cardiovascular Business | December 14, 2022

Corindus, A Siemens Healthineers Company, Is Now Siemens Healthineers Endovascular Robotics

Corindus, A Siemens Healthineers Company, has officially rebranded as Siemens Healthineers

Corindus, A Siemens Healthineers Company, has officially rebranded as Siemens Healthineers

December 14, 2022 — Corindus, A Siemens Healthineers Company, has been rebranded to Siemens Healthineers Endovascular Robotics, a dedicated business within the Advanced Therapies area of Siemens Healthineers. This brand unification is the final step of the company integration process that commenced in 2019 with the acquisition of Corindus by Siemens Healthineers. The aim of the Endovascular Robotics business is to advance interventions with robotics and change the way that care is delivered through innovations that enhance physician technique and bring precision to interventional procedures.

As the dedicated Endovascular Robotics business of Siemens Healthineers, we have access to the resources of a leading global medical technology company, allowing us to continue to advance our vision of developing innovative, image-guided robotic solutions. Siemens Healthineers Endovascular Robotics will continue to offer the CorPath GRX System to support endovascular procedures while working to revolutionize treatment of emergent conditions by developing technologies to provide specialized and timely medical care to more patients around the world.

This transition is actively underway, and all Corindus channels, including the company website and social media profiles, will officially shut down on December 16, 2022. All the materials previously shared via the Corindus website can now be accessed on the Siemens Healthineers website in the Endovascular Robotics section at https://www.siemens-healthineers.com/endovascular-robotics.

Wayne Markowitz, Worldwide Executive Vice President of Siemens Healthineers and Head of Endovascular Robotics, said, “The completion of our brand evolution marks the final step to becoming a united company and we remain focused on pioneering breakthroughs for everyone, everywhere. Our flagship product, the CorPath GRX System, is designed to support endovascular interventions, and we look forward to working with our customers as Siemens Healthineers Endovascular Robotics while fueling our vision to connect more patients to advanced care.”

For more information: https://www.siemens-healthineers.com/endovascular-robotics


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now